(4R,6S,9S)-19-bromo-9-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-16-methylidene-8,11-dioxo-3,12-dioxa-7,10-diazatricyclo[15.3.1.14,7]docosa-1(21),17,19-triene-6-carboxamide;(1R,12E,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10,12-tetraen-4-yne-25-carboxamide;(1R,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10-triene-25-carboxamide;(1R,25S)-22-cyclohexyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-13-methylidene-20,23-dioxo-2,19-dioxa-21,24-diazatetracyclo[22.2.1.03,12.06,11]heptacosa-3(12),4,6,8,10-pentaene-25-carboxamide;methane
C151H211BrN16O32S4 — CID 159467349
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R,6S,9S)-19-bromo-9-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-16-methylidene-8,11-dioxo-3,12-dioxa-7,10-diazatricyclo[15.3.1.14,7]docosa-1(21),17,19-triene-6-carboxamide;(1R,12E,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10,12-tetraen-4-yne-25-carboxamide;(1R,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10-triene-25-carboxamide;(1R,25S)-22-cyclohexyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-13-methylidene-20,23-dioxo-2,19-dioxa-21,24-diazatetracyclo[22.2.1.03,12.06,11]heptacosa-3(12),4,6,8,10-pentaene-25-carboxamide;methane
(4R,6S,9S)-19-bromo-9-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-16-methylidene-8,11-dioxo-3,12-dioxa-7,10-diazatricyclo[15.3.1.14,7]docosa-1(21),17,19-triene-6-carboxamide;(1R,12E,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10,12-tetraen-4-yne-25-carboxamide;(1R,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10-triene-25-carboxamide;(1R,25S)-22-cyclohexyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-13-methylidene-20,23-dioxo-2,19-dioxa-21,24-diazatetracyclo[22.2.1.03,12.06,11]heptacosa-3(12),4,6,8,10-pentaene-25-carboxamide;methane (PubChem CID 159467349) has the molecular formula C151H211BrN16O32S4 and a molecular weight of 2970.60 g/mol. Its IUPAC name is (4R,6S,9S)-19-bromo-9-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-16-methylidene-8,11-dioxo-3,12-dioxa-7,10-diazatricyclo[15.3.1.14,7]docosa-1(21),17,19-triene-6-carboxamide;(1R,12E,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10,12-tetraen-4-yne-25-carboxamide;(1R,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10-triene-25-carboxamide;(1R,25S)-22-cyclohexyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-13-methylidene-20,23-dioxo-2,19-dioxa-21,24-diazatetracyclo[22.2.1.03,12.06,11]heptacosa-3(12),4,6,8,10-pentaene-25-carboxamide;methane.
Molecular Properties
| Compound Name | (4R,6S,9S)-19-bromo-9-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-16-methylidene-8,11-dioxo-3,12-dioxa-7,10-diazatricyclo[15.3.1.14,7]docosa-1(21),17,19-triene-6-carboxamide;(1R,12E,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10,12-tetraen-4-yne-25-carboxamide;(1R,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10-triene-25-carboxamide;(1R,25S)-22-cyclohexyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-13-methylidene-20,23-dioxo-2,19-dioxa-21,24-diazatetracyclo[22.2.1.03,12.06,11]heptacosa-3(12),4,6,8,10-pentaene-25-carboxamide;methane |
|---|---|
| PubChem CID | 159467349 |
| Molecular Formula | C151H211BrN16O32S4 |
| Molecular Weight | 2970.60 g/mol |
| Exact Mass | 2967.34 |
| IUPAC Name | (4R,6S,9S)-19-bromo-9-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-16-methylidene-8,11-dioxo-3,12-dioxa-7,10-diazatricyclo[15.3.1.14,7]docosa-1(21),17,19-triene-6-carboxamide;(1R,12E,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10,12-tetraen-4-yne-25-carboxamide;(1R,22S,25S)-22-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-20,23-dioxo-2,19-dioxa-21,24-diazatricyclo[22.2.1.06,11]heptacosa-6,8,10-triene-25-carboxamide;(1R,25S)-22-cyclohexyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-13-methylidene-20,23-dioxo-2,19-dioxa-21,24-diazatetracyclo[22.2.1.03,12.06,11]heptacosa-3(12),4,6,8,10-pentaene-25-carboxamide;methane |
| SMILES | C.C.C.C.C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)C(C1CCCCC1)NC(=O)OCCCCCC(=C)c1c(ccc3ccccc13)O2)C(=O)NS(=O)(=O)C1CC1.C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCCCCC/C=C/c1ccccc1C#CCO2)C(=O)NS(=O)(=O)C1CC1.C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCCCCCCCc1ccccc1CCCO2)C(=O)NS(=O)(=O)C1CC1.C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](CCCC)NC(=O)OCCCC(=C)c1cc(Br)cc(c1)CO2)C(=O)NS(=O)(=O)C1CC1 |
| InChI | InChI=1S/C40H50N4O8S.C37H54N4O8S.C37H48N4O8S.C33H43BrN4O8S.4CH4/c1-3-28-23-40(28,38(47)43-53(49,50)30-18-19-30)42-36(45)32-22-29-24-44(32)37(46)35(27-14-7-4-8-15-27)41-39(48)51-21-11-5-6-12-25(2)34-31-16-10-9-13-26(31)17-20-33(34)52-29;2*1-5-27-23-37(27,34(44)40-50(46,47)29-18-19-29)39-32(42)30-22-28-24-41(30)33(43)31(36(2,3)4)38-35(45)49-20-12-8-6-7-9-14-25-15-10-11-16-26(25)17-13-21-48-28;1-4-6-9-27-30(40)38-18-25(46-19-21-13-22(15-24(34)14-21)20(3)8-7-12-45-32(42)35-27)16-28(38)29(39)36-33(17-23(33)5-2)31(41)37-47(43,44)26-10-11-26;;;;/h3,9-10,13,16-17,20,27-30,32,35H,1-2,4-8,11-12,14-15,18-19,21-24H2,(H,41,48)(H,42,45)(H,43,47);5,10-11,15-16,27-31H,1,6-9,12-14,17-24H2,2-4H3,(H,38,45)(H,39,42)(H,40,44);5,9-11,14-16,27-31H,1,6-8,12,18-24H2,2-4H3,(H,38,45)(H,39,42)(H,40,44);5,13-15,23,25-28H,2-4,6-12,16-19H2,1H3,(H,35,42)(H,36,39)(H,37,41);4*1H4/b;;14-9+;;;;;/t28-,29-,32+,35?,40-;2*27-,28-,30+,31-,37-;23-,25-,27+,28+,33-;;;;/m1111..../s1 |
| InChIKey | LVIXYPJJCQCDDZ-NOPTZPGWSA-N |
| XLogP | 18.70 |
| TPSA | 640.84 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 204 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2970.60 |
| LogP ≤ 5 | 18.70 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 32 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159467349 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.